LU85631A1 - Oxazolidine - Google Patents

Oxazolidine Download PDF

Info

Publication number
LU85631A1
LU85631A1 LU85631A LU85631A LU85631A1 LU 85631 A1 LU85631 A1 LU 85631A1 LU 85631 A LU85631 A LU 85631A LU 85631 A LU85631 A LU 85631A LU 85631 A1 LU85631 A1 LU 85631A1
Authority
LU
Luxembourg
Prior art keywords
phenyl
compounds according
formula
methyl
radical
Prior art date
Application number
LU85631A
Other languages
German (de)
English (en)
Inventor
Marcel Mueller
Leo Alig
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH6070/83A external-priority patent/CH655931A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of LU85631A1 publication Critical patent/LU85631A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
LU85631A 1983-11-10 1984-11-07 Oxazolidine LU85631A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH607083 1983-11-10
CH6070/83A CH655931A5 (en) 1983-11-10 1983-11-10 Oxazolidines
CH449984 1984-09-20
CH449984 1984-09-20

Publications (1)

Publication Number Publication Date
LU85631A1 true LU85631A1 (fr) 1986-06-04

Family

ID=25695620

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85631A LU85631A1 (fr) 1983-11-10 1984-11-07 Oxazolidine

Country Status (22)

Country Link
US (2) US4743604A (fr)
AT (1) AT387771B (fr)
AU (1) AU576531B2 (fr)
BE (1) BE900983A (fr)
CA (1) CA1249992A (fr)
DE (1) DE3438411A1 (fr)
DK (1) DK520584A (fr)
ES (1) ES8606863A1 (fr)
FI (1) FI844152L (fr)
FR (1) FR2554814B1 (fr)
GB (1) GB2149405B (fr)
HU (1) HU193465B (fr)
IL (1) IL73427A (fr)
IT (1) IT1177033B (fr)
LU (1) LU85631A1 (fr)
MC (1) MC1641A1 (fr)
NL (1) NL8403308A (fr)
NO (1) NO844501L (fr)
NZ (1) NZ210105A (fr)
PH (1) PH22462A (fr)
PT (1) PT79485B (fr)
SE (1) SE463099B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968707A (en) * 1987-06-10 1990-11-06 Pfizer Inc. Oxazolidin-2-one derivatives as hypoglycemic agents
FI892341A (fi) * 1988-06-10 1989-12-11 Hoffmann La Roche Propanolaminderivat.
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
SK111195A3 (en) * 1994-09-13 1997-06-04 Sandoz Technology Ltd Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
US8036727B2 (en) 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
US7822452B2 (en) 2004-08-11 2010-10-26 Glt Acquisition Corp. Method for data reduction and calibration of an OCT-based blood glucose monitor
US7254429B2 (en) * 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
WO2009111542A2 (fr) 2008-03-04 2009-09-11 Glucolight Corporation Procédés et systèmes pour l'estimation d'un niveau d'analyte en tomographie par cohérence optique
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA979912A (en) * 1970-06-22 1975-12-16 Frederic P. Hauck Tetrahydronaphthyloxyaminopropanols and related compounds
GB1301134A (en) * 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES

Also Published As

Publication number Publication date
SE8405632D0 (sv) 1984-11-09
CA1249992A (fr) 1989-02-14
HUT36103A (en) 1985-08-28
NO844501L (no) 1985-05-13
DE3438411A1 (de) 1985-05-30
NL8403308A (nl) 1985-06-03
FI844152A0 (fi) 1984-10-22
SE463099B (sv) 1990-10-08
ATA355384A (de) 1988-08-15
PT79485B (en) 1987-01-13
PH22462A (en) 1988-09-12
AU576531B2 (en) 1988-09-01
GB8428335D0 (en) 1984-12-19
AU3527584A (en) 1985-05-16
FR2554814A1 (fr) 1985-05-17
AT387771B (de) 1989-03-10
DK520584D0 (da) 1984-11-01
IL73427A (en) 1988-02-29
IT1177033B (it) 1987-08-26
BE900983A (fr) 1985-05-06
GB2149405A (en) 1985-06-12
MC1641A1 (fr) 1986-01-09
NZ210105A (en) 1988-10-28
PT79485A (en) 1984-12-01
HU193465B (en) 1987-10-28
IT8423307A1 (it) 1986-04-25
FI844152L (fi) 1985-05-11
ES537487A0 (es) 1986-05-01
US4743604A (en) 1988-05-10
IL73427A0 (en) 1985-02-28
GB2149405B (en) 1987-07-01
DK520584A (da) 1985-05-11
ES8606863A1 (es) 1986-05-01
SE8405632L (sv) 1985-05-11
FR2554814B1 (fr) 1988-03-11
IT8423307A0 (it) 1984-10-25
US4871755A (en) 1989-10-03

Similar Documents

Publication Publication Date Title
EP0101069B1 (fr) Phénéthanolamines
EP0140243B1 (fr) Phénoxypropanolamines
LU85631A1 (fr) Oxazolidine
EP0254856B1 (fr) Dérivés de pyridinéthanolamines
EP0400011B1 (fr) Phenylethanolamines
EP0094595B1 (fr) Dérivés de l'aziridine et de la phényléthanolamine
DE2332837A1 (de) Amine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0198412B1 (fr) Dérivés de la phénéthanolamine
AU622907B2 (en) Propanolamine derivatives
DE2633245A1 (de) 4-hydroxy-1,3-benzoldimethanolverbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
EP0013749A1 (fr) Hexahydro-1,4-oxazépines, procédé pour leur préparation et compositions pharmaceutiques les contenant
DE2404328A1 (de) Verfahren zur herstellung von alpha(l-aralkylaminoalkyl)-aralkoxybenzylalkoholen
AU617353B2 (en) Pyridylethanolamines
DE2644972A1 (de) Thiaprostaglandine
DE1518334C3 (de) Substituierte Benzylamme und ihre Salze sowie Verfahren zu ihrer Herstellung
CH655931A5 (en) Oxazolidines
DE2743493A1 (de) Amine, verfahren zu deren herstellung und sie enthaltende arzneimittel
EP0386603A2 (fr) Bisphénéthanolamine
KR820002065B1 (ko) 펜에탄올 아민류의 제조방법
AT353272B (de) Verfahren zur herstellung von neuen piperidin- derivaten sowie von deren salzen und optisch aktiven formen
AT371101B (de) Verfahren zur herstellung neuer optisch aktiver phenethanolamine und der pharmazeutisch unbedenklichen salze hiervon
DE3025325A1 (de) Neue 13-thiaprostaglandin-zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von 13-thiaprostaglandin-derivaten
DE1768366B2 (de) 3-hydroxy-alpha-(1-aminoaethyl)benzylalkohol-derivate und diese enthaltende arzneimittel
DE3000441A1 (de) Anilinderivate,,diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
DE2411640A1 (de) Verfahren zur herstellung von neuen polycyclischen aminen